| Dr Marvin Mcgowan, DO | |
|
1152 Wood St, California, PA 15419-1260 | |
| (724) 632-6801 | |
| (724) 938-7853 |
| Full Name | Dr Marvin Mcgowan |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 1152 Wood St, California, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851382535 | NPI | - | NPPES |
| 1012069240001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS012547 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Outreach Wellness Center | 6507186772 | 28 |
News Archive
Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.
Regular handwashing by hospital staff and visitors did more to prevent the spread of the MRSA superbug than isolating infected patients.
At a meeting on the sidelines of the 67th U.N. General Assembly on Wednesday in New York, the MDG Advocacy Group - which comprises representatives from the private sector, academia, governments and civil society - "urged the international community to step up efforts for the final three years of the Millennium Development Goals (MDGs)," the U.N. News Centre reports.
A collaborative network of European and North American scientists, including from the University of North Carolina at Chapel Hill School of Medicine, have been awarded a total of $6 million over five years to explore the biology of heart failure and to find new therapies for it.
› Verified 8 days ago
| Entity Name | Centerville Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801877048 PECOS PAC ID: 7214837202 Enrollment ID: O20040427000681 |
News Archive
Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.
Regular handwashing by hospital staff and visitors did more to prevent the spread of the MRSA superbug than isolating infected patients.
At a meeting on the sidelines of the 67th U.N. General Assembly on Wednesday in New York, the MDG Advocacy Group - which comprises representatives from the private sector, academia, governments and civil society - "urged the international community to step up efforts for the final three years of the Millennium Development Goals (MDGs)," the U.N. News Centre reports.
A collaborative network of European and North American scientists, including from the University of North Carolina at Chapel Hill School of Medicine, have been awarded a total of $6 million over five years to explore the biology of heart failure and to find new therapies for it.
› Verified 8 days ago
| Entity Name | Central Outreach Wellness Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063804136 PECOS PAC ID: 6507186772 Enrollment ID: O20150529000928 |
News Archive
Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.
Regular handwashing by hospital staff and visitors did more to prevent the spread of the MRSA superbug than isolating infected patients.
At a meeting on the sidelines of the 67th U.N. General Assembly on Wednesday in New York, the MDG Advocacy Group - which comprises representatives from the private sector, academia, governments and civil society - "urged the international community to step up efforts for the final three years of the Millennium Development Goals (MDGs)," the U.N. News Centre reports.
A collaborative network of European and North American scientists, including from the University of North Carolina at Chapel Hill School of Medicine, have been awarded a total of $6 million over five years to explore the biology of heart failure and to find new therapies for it.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marvin Mcgowan, DO 1070 Old National Pike, Fredericktown, PA 15333-2114 Ph: (724) 632-6801 | Dr Marvin Mcgowan, DO 1152 Wood St, California, PA 15419-1260 Ph: (724) 632-6801 |
News Archive
Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.
Regular handwashing by hospital staff and visitors did more to prevent the spread of the MRSA superbug than isolating infected patients.
At a meeting on the sidelines of the 67th U.N. General Assembly on Wednesday in New York, the MDG Advocacy Group - which comprises representatives from the private sector, academia, governments and civil society - "urged the international community to step up efforts for the final three years of the Millennium Development Goals (MDGs)," the U.N. News Centre reports.
A collaborative network of European and North American scientists, including from the University of North Carolina at Chapel Hill School of Medicine, have been awarded a total of $6 million over five years to explore the biology of heart failure and to find new therapies for it.
› Verified 8 days ago
Dr. Allison Francis Verenna, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 415 3rd St, California, PA 15419 Phone: 724-938-7466 Fax: 724-938-7470 |